Legal & General Group’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.2K | Sell |
5,763
-40,371
| -88% | -$380K | ﹤0.01% | 2698 |
|
|
2025
Q1 | $250K | Sell |
46,134
-129
| -0.3% | -$700 | ﹤0.01% | 2579 |
|
|
2024
Q4 | $345K | Buy |
46,263
+5,984
| +15% | +$44.6K | ﹤0.01% | 2578 |
|
|
2024
Q3 | $322K | Hold |
40,279
| – | – | ﹤0.01% | 2594 |
|
|
2024
Q2 | $350K | Buy |
40,279
+3,364
| +9% | +$29.3K | ﹤0.01% | 2550 |
|
|
2024
Q1 | $763K | Buy |
36,915
+34,287
| +1,305% | +$709K | ﹤0.01% | 2280 |
|
|
2023
Q4 | $60.7K | Sell |
2,628
-105
| -4% | -$2.43K | ﹤0.01% | 2784 |
|
|
2023
Q3 | $21.8K | Buy |
2,733
+91
| +3% | +$727 | ﹤0.01% | 2991 |
|
|
2023
Q2 | $22.9K | Hold |
2,642
| – | – | ﹤0.01% | 3062 |
|
|
2023
Q1 | $7.76K | Hold |
2,642
| – | – | ﹤0.01% | 3242 |
|
|
2022
Q4 | $9.25K | Hold |
2,642
| – | – | ﹤0.01% | 3282 |
|
|
2022
Q3 | $21K | Hold |
2,642
| – | – | ﹤0.01% | 3192 |
|
|
2022
Q2 | $21K | Buy |
2,642
+611
| +30% | +$4.86K | ﹤0.01% | 3216 |
|
|
2022
Q1 | $25K | Buy |
2,031
+343
| +20% | +$4.22K | ﹤0.01% | 3173 |
|
|
2021
Q4 | $21K | Hold |
1,688
| – | – | ﹤0.01% | 3263 |
|
|
2021
Q3 | $18K | Buy |
+1,688
| New | +$18K | ﹤0.01% | 3305 |
|
|
2020
Q2 | – | Sell |
-845
| Closed | -$9K | – | 3425 |
|
|
2020
Q1 | $9K | Sell |
845
-353
| -29% | -$3.76K | ﹤0.01% | 3182 |
|
|
2019
Q4 | $19K | Buy |
1,198
+163
| +16% | +$2.59K | ﹤0.01% | 3199 |
|
|
2019
Q3 | $19K | Hold |
1,035
| – | – | ﹤0.01% | 3152 |
|
|
2019
Q2 | $17K | Buy |
+1,035
| New | +$17K | ﹤0.01% | 3256 |
|